The Vicenza site will run about 54,000 square feet in size.
CMP Phar.ma, a company that specializes in the production of inspection systems for the pharma industry, has welcomed a new location in Vicenza, Italy. CMP Phar.ma’s parent company, Marchesini Group, is investing $7.4 million into the 54,000 square-foot site, with more than half of that being used for production.
As far back as 1982, a little more than 10 years after its incorporation, CMP Phar.ma introduced an automatic ampoule inspection machine with laser lighting onto the market. Since then, CMP Phar.ma has consolidated its position by establishing a product portfolio which now includes various inspection machines, not only for ampoules but also for vials, pre-filled syringes, and freeze-dried products.
By now being under Marchesini Group umbrella, CMP Phar.ma can now contribute its inspection machines to larger production lines, including those used by Big Pharma for packaging COVID-19 vaccines and cancer drugs.
Strategic Trends in Pharmaceutical Manufacturing for Industry Leaders
March 10th 2025This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.